March 10, 2025 - 16:48

Thousands gathered in Las Vegas for the highly anticipated annual health technology conference, showcasing the latest innovations and trends in the industry. This year's event was marked by an overwhelming focus on artificial intelligence and cybersecurity, reflecting the growing importance of these areas in healthcare management and patient safety.
Attendees engaged in discussions about the transformative potential of AI in streamlining operations and enhancing patient care, while cybersecurity experts highlighted the critical need for robust protection against increasing threats. However, amid the excitement over technological advancements, many participants expressed concern about the shifting political landscape in Washington and its implications for the healthcare sector.
As regulatory changes loom, industry leaders are keenly aware of the potential impact on funding, innovation, and the overall direction of health technology. The conference served as a vital platform for networking, knowledge sharing, and addressing the challenges that lie ahead in this rapidly evolving field.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...